September 11, 2013

Shopko will use proceeds from sales of some women's clothing to support breast cancer research, the mass merchandiser said.

September 10, 2013

European regulators have approved the European Union's first biosimilar monoclonal antibody. The new product, made by U.S.-based Hospira, comes seven years after the approval of Europe's first biosimilar.

September 10, 2013

An organization of nonprofit academic medical centers has created a new specialty pharmacy program that it said would improve continuity of care and improve access to specialty drugs.

September 9, 2013

The CancerCare Co-Payment Assistance Foundation has launched a new website and customer relationship management software program, the group said Monday.

September 6, 2013

The Food and Drug Administration has approved a drug made by Celgene for treating patients with pancreatic cancer that has spread to other parts of the body, the agency said Friday.

September 5, 2013

A webinar next week about specialty drugs expected to enter the U.S. marketplace over the next 12 months and strategies that can improve patient outcomes while keeping costs down will include a speaker from one of the country's biggest specialty pharmacies.

September 5, 2013

Japanese drug maker Otsuka Pharmaceutical Co. is buying U.S.-based Astex Pharmaceuticals for $886 million, Otsuka said Thursday.

September 4, 2013

A joint venture founded by GlaxoSmithKline and Pfizer focused on treatments for HIV has expanded its support of community organizations in the South.

September 3, 2013

The Food and Drug Administration has approved a new vial size for a treatment for a rare immune system disorder.

September 3, 2013

Over the last few years, many drug makers have offered coupons and co-payment-assistance programs as a way to reduce patients' out-of-pocket spending on medications, but a new study questions whether they really reduce spending in the long run and whether they're even legal.

September 3, 2013

A new opioid painkiller drug made by Upsher-Smith Labs will become available on Wednesday, the drug maker said.

August 29, 2013

The Food and Drug Administration has approved the latest drug in BD's Simplist line, the company said Thursday.

August 29, 2013

The Food and Drug Administration is concerned about bills in several state legislatures that seek to restrict pharmacists' ability to dispense biosimilars, according to published reports.

August 28, 2013

McKesson Specialty Health and The US Oncology Network on Wednesday announced the appointment of Michael Seiden as chief medical officer, effective Sept, 22.

August 28, 2013

The results of a large survey of patients with rheumatoid arthritis have been published, the company that conducted the survey said Wednesday.

August 28, 2013

The global market for drug packaging is expected to experience tremendous growth over the next few years, according to a new report.

August 28, 2013

A company that has developed an edible security platform for addressing the global problem of counterfeit foods and medicines has been named a 2014 Technology Pioneer by the World Economic Forum.

August 27, 2013

AstraZeneca has bought Maryland-based biotech company Amplimmune, the drug maker said.

August 27, 2013

Lawmakers in California have passed a bill that would restrict the use of follow-on versions of biotech drugs known as biosimilars, according to published reports.

August 26, 2013

Biotech company Amgen is buying Onyx Pharmaceuticals, the companies said Sunday.

August 26, 2013

The Food and Drug Administration approved a new drug made by Ceptaris Therapeutics for treating a type of lymphoma, the company said.

August 26, 2013

A new report by the American Academy of Pediatrics indicates that it is safe for women to take the medications and vaccinations they need while breast-feeding.

August 26, 2013

Former Kinray owner Stewart Rahr has made a large donation to an organization looking for a cure for prostate cancer.

August 23, 2013

HIV continues to disproportionately affect African-Americans and Hispanics, prompting a recent seminar in New York that included pop singer Alicia Keys, New York Democratic Rep. Charlie Rangel and others.